Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Dimensional US Targeted Value ETF
DFAT
$14.8B
| $227K | ﹤0.01% |
3,900
-18,900
| -83% | -$1.08M |
|
|
GRO
3102
Brazil Potash Corp
GRO
$132M
| $227K | ﹤0.01% |
84,325
+50,025
| +146% | +$95.8K |
|
3103
Ebang International Holdings
EBON
$12.2M
| $226K | ﹤0.01% |
50,113
+900
| +2% | +$3.87K |
|
3104
MetroCity Bankshares
MCBS
$1.05B
| $224K | ﹤0.01% |
8,094
-10,155
| -56% | -$295K |
|
|
ASPSZ
3105
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$7.05M
| $224K | ﹤0.01% |
386,322
-31,200
| -7% | -$22.9K |
|
|
AHG
3106
Akso Health Group
AHG
$1.11B
| $224K | ﹤0.01% |
129,198
-1,600
| -1% | -$2.76K |
|
3107
Gain Therapeutics
GANX
$92.6M
| $223K | ﹤0.01% |
126,100
+32,100
| +34% | +$54.1K |
|
3108
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.07B
| $222K | ﹤0.01% |
10,300
-49,000
| -83% | -$1.03M |
|
|
SIFY
3109
Sify Technologies
SIFY
$1.15B
| $221K | ﹤0.01% |
+16,200
| New | +$137K |
|
|
PBBK
3110
DELISTED
PB Bankshares
PBBK
| $221K | ﹤0.01% |
+11,500
| New | +$217K |
|
|
RJET
3111
Republic Airways Holdings
RJET
$964M
| $218K | ﹤0.01% |
11,186
+4,506
| +67% | +$79.6K |
|
3112
CalciMedica
CALC
$20.2M
| $215K | ﹤0.01% |
70,000
+34,000
| +94% | +$97.8K |
|
3113
Hingham Institution for Saving
HIFS
$686M
| $215K | ﹤0.01% |
816
-6,373
| -89% | -$1.7M |
|
|
LONA
3114
LeonaBio Inc
LONA
$73.9M
| $215K | ﹤0.01% |
51,924
+27,824
| +115% | +$109K |
|
|
FMFC
3115
Kandal M Venture Ltd
FMFC
$4.32M
| $215K | ﹤0.01% |
+14,600
| New | +$131K |
|
|
BKV
3116
BKV Corp
BKV
$2.84B
| $213K | ﹤0.01% |
9,200
-30,600
| -77% | -$667K |
|
|
DRUG
3117
Bright Minds Biosciences
DRUG
$765M
| $212K | ﹤0.01% |
+3,500
| New | +$136K |
|
3118
Freightos
CRGO
$68.2M
| $211K | ﹤0.01% |
63,900
+18,000
| +39% | +$53.9K |
|
3119
Cardiff Oncology
CRDF
$76.6M
| $210K | ﹤0.01% |
101,800
-27,890
| -22% | -$77.1K |
|
3120
ExxonMobil
XOM
$652B
| $209K | ﹤0.01% |
1,865
-495,117
| -100% | -$55M |
|
3121
Avalon Holdings
AWX
$10.9M
| $209K | ﹤0.01% |
80,210
-3,775
| -4% | -$9.53K |
|
|
SSKN
3122
DELISTED
Strata Skin Sciences
SSKN
| $209K | ﹤0.01% |
101,530
+3,500
| +4% | +$6.94K |
|
3123
Xenon Pharmaceuticals
XENE
$6.21B
| $209K | ﹤0.01% |
5,200
-3,400
| -40% | -$120K |
|
|
LNKB
3124
DELISTED
LINKBANCORP
LNKB
| $208K | ﹤0.01% |
29,200
+10,800
| +59% | +$78.3K |
|
|
BLTE
3125
Belite Bio
BLTE
$6.67B
| $208K | ﹤0.01% |
2,812
-1,488
| -35% | -$97.7K |
|
Similar funds
Jim Simons's Q3 2025 Portfolio in Review
As of Q3 2025, Jim Simons held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class C worth $419M.
- Jim Simons's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Jim Simons's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Jim Simons fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Jim Simons's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Jim Simons opened 516 new positions and closed 581 in Q3 2025.
- Jim Simons's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.